| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.737 | 0.004 | 0.737 | Vasodilator | 0.54 0.009 CID_186984 | ||
| 0.599 | 0.008 | 0.599 | GABA C receptor rho-3 antagonist | 0.407 0.058 CID_186984 | ||
| 0.473 | 0.017 | 0.473 | DNA damaging | 0.28 0.065 CID_186984 | ||
| 0.468 | 0.033 | 0.468 | 5 Hydroxytryptamine release stimulant | 0.192 0.128 CID_186984 | ||
| 0.459 | 0.038 | 0.459 | Vasodilator, peripheral | 0.285 0.105 CID_186984 | ||
| 0.424 | 0.007 | 0.424 | Alkylator | 0.248 0.017 CID_186984 | ||
| 0.426 | 0.01 | 0.426 | 5 Hydroxytryptamine uptake stimulant | 0.272 0.062 CID_186984 | ||
| 0.422 | 0.006 | 0.422 | Tyrosine 3 hydroxylase inhibitor | 0.323 0.024 CID_186984 | ||
| 0.372 | 0.026 | 0.372 | DNA synthesis inhibitor | 0.326 0.036 CID_186984 | ||
| 0.372 | 0.034 | 0.372 | Free radical scavenger | 0.179 0.115 CID_186984 | ||
| 0.419 | 0.1 | 0.419 | Caspase 9 stimulant | 0.281 0.215 CID_186984 | ||
| 0.352 | 0.055 | 0.352 | Aldehyde oxidase inhibitor | 0.173 0.121 CID_186984 | ||
| 0.347 | 0.057 | 0.347 | Vasodilator, coronary | 0.253 0.132 CID_186984 | ||
| 0.291 | 0.004 | 0.291 | Thioredoxin inhibitor | 0.215 0.007 CID_186984 | ||
| 0.29 | 0.01 | 0.29 | GABA C receptor agonist | 0.202 0.02 CID_186984 | ||
| 0.293 | 0.026 | 0.293 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.232 0.051 CID_186984 | ||
| 0.277 | 0.015 | 0.277 | Succinate dehydrogenase inhibitor | 0.229 0.03 CID_186984 | ||
| 0.272 | 0.01 | 0.272 | Ferrochelatase inhibitor | 0.166 0.032 CID_186984 | ||
| 0.286 | 0.026 | 0.286 | Thrombolytic | 0.137 0.092 CID_186984 | ||
| 0.337 | 0.081 | 0.337 | Transcription factor NF kappa B inhibitor | 0.19 0.179 CID_186984 | ||
| 0.354 | 0.112 | 0.354 | 5 Hydroxytryptamine release inhibitor | |||
| 0.294 | 0.053 | 0.294 | Superoxide dismutase inhibitor | 0.176 0.146 CID_186984 | ||
| 0.316 | 0.078 | 0.316 | Antithrombotic | 0.213 0.161 CID_186984 | ||
| 0.251 | 0.023 | 0.251 | Alpha-N-acetylglucosaminidase inhibitor | 0.177 0.042 CID_186984 | ||
| 0.232 | 0.008 | 0.232 | GABA C receptor antagonist | 0.166 0.022 CID_186984 | ||
| 0.357 | 0.143 | 0.357 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.292 | 0.081 | 0.332 | Immunostimulant | 0.332 0.07 CID_186984 | CID_186984 | |
| 0.228 | 0.017 | 0.228 | GABA C receptor rho-2 antagonist | 0.168 0.053 CID_186984 | ||
| 0.201 | 0.002 | 0.201 | Nitric oxide donor | 0.138 0.003 CID_186984 | ||
| 0.209 | 0.014 | 0.209 | Adenylate kinase inhibitor | 0.179 0.018 CID_186984 | ||
| 0.287 | 0.1 | 0.287 | Cholesterol antagonist | 0.187 0.177 CID_186984 | ||
| 0.194 | 0.009 | 0.194 | GABA C receptor rho-1 antagonist | 0.144 0.024 CID_186984 | ||
| 0.24 | 0.055 | 0.24 | Anesthetic general | |||
| 0.192 | 0.012 | 0.192 | Creatine kinase inhibitor | 0.134 0.031 CID_186984 | ||
| 0.272 | 0.096 | 0.272 | Interleukin 2 agonist | 0.227 0.147 CID_186984 | ||
| 0.293 | 0.128 | 0.293 | Histamine release inhibitor | |||
| 0.278 | 0.115 | 0.278 | Calcium channel activator | |||
| 0.171 | 0.012 | 0.171 | Ca2+-transporting ATPase inhibitor | 0.152 0.037 CID_186984 | ||
| 0.185 | 0.027 | 0.185 | Cathepsin H inhibitor | 0.119 0.077 CID_186984 | ||
| 0.234 | 0.08 | 0.234 | Platelet antagonist | |||
| 0.192 | 0.041 | 0.192 | Arachidonic acid antagonist | 0.151 0.088 CID_186984 | ||
| 0.163 | 0.013 | 0.163 | CYP2A6 inhibitor | |||
| 0.237 | 0.089 | 0.237 | Interleukin agonist | |||
| 0.215 | 0.072 | 0.215 | Psychostimulant | |||
| 0.192 | 0.049 | 0.192 | Phospholipase C inhibitor | 0.158 0.091 CID_186984 | ||
| 0.167 | 0.024 | 0.167 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.149 | 0.009 | 0.149 | Thioredoxin reductase inhibitor | 0.088 0.044 CID_186984 | ||
| 0.168 | 0.031 | 0.168 | Aminopeptidase B inhibitor | 0.138 0.043 CID_186984 | ||
| 0.151 | 0.016 | 0.151 | Acetylcholine release stimulant | |||
| 0.144 | 0.012 | 0.144 | Argininosuccinate synthase inhibitor | 0.121 0.015 CID_186984 | ||
| 0.167 | 0.037 | 0.167 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.138 | 0.01 | 0.138 | Acyl-CoA dehydrogenase inhibitor | 0.108 0.014 CID_186984 | ||
| 0.158 | 0.033 | 0.158 | Falcipain 3 inhibitor | |||
| 0.226 | 0.102 | 0.226 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.165 | 0.042 | 0.165 | Adenylate cyclase stimulant | 0.138 0.084 CID_186984 | ||
| 0.195 | 0.072 | 0.195 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.145 | 0.024 | 0.145 | Prolactin inhibitor | |||
| 0.141 | 0.023 | 0.141 | Triose-phosphate isomerase inhibitor | 0.102 0.046 CID_186984 | ||
| 0.137 | 0.021 | 0.137 | Phosphofructokinase-1 inhibitor | 0.122 0.024 CID_186984 | ||
| 0.156 | 0.04 | 0.156 | DNA intercalator | |||
| 0.202 | 0.086 | 0.202 | Nitric-oxide synthase stimulant | |||
| 0.127 | 0.014 | 0.127 | Glycine receptor antagonist | 0.087 0.047 CID_186984 | ||
| 0.172 | 0.059 | 0.172 | Neurotensin receptor agonist | |||
| 0.138 | 0.025 | 0.138 | Electrolyte absorption antagonist | 0.095 0.065 CID_186984 | ||
| 0.155 | 0.044 | 0.155 | Cyclooxygenase 3 inhibitor | |||
| 0.118 | 0.01 | 0.118 | Androgen agonist | 0.055 0.049 CID_186984 | ||
| 0.156 | 0.048 | 0.156 | Toll-Like receptor 2 antagonist | |||
| 0.153 | 0.046 | 0.203 | Aldehyde dehydrogenase inhibitor | 0.203 0.027 CID_186984 | CID_186984 | |
| 0.227 | 0.12 | 0.227 | Insulysin inhibitor | |||
| 0.139 | 0.035 | 0.139 | Protease inhibitor | 0.128 0.042 CID_186984 | ||
| 0.115 | 0.015 | 0.115 | Alcohol oxidase inhibitor | 0.064 0.033 CID_186984 | ||
| 0.126 | 0.026 | 0.126 | Porphobilinogen synthase inhibitor | 0.068 0.058 CID_186984 | ||
| 0.139 | 0.039 | 0.139 | Mucolytic | 0.106 0.07 CID_186984 | ||
| 0.113 | 0.014 | 0.113 | Ornithine carbamoyltransferase inhibitor | 0.1 0.016 CID_186984 | ||
| 0.14 | 0.041 | 0.14 | DNA repair enzyme inhibitor | 0.122 0.069 CID_186984 | ||
| 0.208 | 0.113 | 0.208 | Spasmolytic | |||
| 0.192 | 0.099 | 0.192 | Angiogenesis stimulant | |||
| 0.216 | 0.125 | 0.216 | Gastrin inhibitor | |||
| 0.196 | 0.105 | 0.234 | Peptidyltransferase inhibitor | 0.234 0.063 CID_186984 | CID_186984 | |
| 0.125 | 0.035 | 0.125 | Anabolic | 0.097 0.067 CID_186984 | ||
| 0.104 | 0.014 | 0.104 | Vanilloid 4 agonist | |||
| 0.234 | 0.146 | 0.234 | Sodium/bile acid cotransporter inhibitor | |||
| 0.117 | 0.03 | 0.117 | NADH dehydrogenase inhibitor | 0.103 0.041 CID_186984 | ||
| 0.134 | 0.05 | 0.134 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.13 | 0.046 | 0.13 | Photosensitizer | |||
| 0.106 | 0.026 | 0.106 | Glutamate decarboxylase inhibitor | 0.077 0.047 CID_186984 | ||
| 0.121 | 0.042 | 0.121 | UDP-glucose 4-epimerase inhibitor | 0.101 0.06 CID_186984 | ||
| 0.154 | 0.076 | 0.154 | Peroxidase inhibitor | |||
| 0.114 | 0.037 | 0.114 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.094 | 0.018 | 0.094 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.07 0.059 CID_186984 | ||
| 0.133 | 0.058 | 0.133 | Anesthetic local | |||
| 0.104 | 0.029 | 0.104 | Glutamate dehydrogenase inhibitor | 0.093 0.035 CID_186984 | ||
| 0.114 | 0.043 | 0.114 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.092 0.062 CID_186984 | ||
| 0.115 | 0.045 | 0.115 | Sphingomyelinase inhibitor | |||
| 0.099 | 0.03 | 0.099 | Interferon agonist | |||
| 0.132 | 0.063 | 0.132 | Vanilloid 1 agonist | |||
| 0.079 | 0.012 | 0.079 | Alpha-mannosidase inhibitor | 0.069 0.018 CID_186984 | ||
| 0.231 | 0.165 | 0.305 | Immunosuppressant | 0.305 0.112 CID_186984 | CID_186984 | |
| 0.143 | 0.077 | 0.143 | Thiol protease inhibitor | |||
| 0.093 | 0.028 | 0.093 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.186 | 0.122 | 0.186 | RNA-directed DNA polymerase inhibitor | |||
| 0.106 | 0.044 | 0.106 | Calcium antagonist | |||
| 0.086 | 0.026 | 0.086 | Carbamoyl phosphate synthetase inhibitor | 0.077 0.03 CID_186984 | ||
| 0.11 | 0.051 | 0.11 | Factor V inhibitor | |||
| 0.116 | 0.059 | 0.116 | 5 Hydroxytryptamine 3A agonist | |||
| 0.08 | 0.024 | 0.08 | Interferon inducer | |||
| 0.079 | 0.026 | 0.079 | Exportin-1 inhibitor | |||
| 0.088 | 0.035 | 0.088 | Aminopeptidase I inhibitor | 0.066 0.059 CID_186984 | ||
| 0.068 | 0.016 | 0.068 | Lysophosphatidic acid 3 receptor antagonist | 0.047 0.041 CID_186984 | ||
| 0.091 | 0.039 | 0.091 | Estrogen-related receptor beta agonist | |||
| 0.066 | 0.014 | 0.066 | Glucose-6-phosphate isomerase inhibitor | 0.054 0.024 CID_186984 | ||
| 0.098 | 0.046 | 0.098 | Ornithine decarboxylase inhibitor | |||
| 0.11 | 0.059 | 0.11 | Expectorant | |||
| 0.088 | 0.037 | 0.088 | GABA aminotransferase inhibitor | |||
| 0.082 | 0.031 | 0.082 | Phospholipase D inhibitor | |||
| 0.084 | 0.034 | 0.084 | GABA B receptor agonist | |||
| 0.171 | 0.121 | 0.171 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.062 | 0.015 | 0.062 | Mannosidase inhibitor | 0.053 0.023 CID_186984 | ||
| 0.059 | 0.014 | 0.059 | Geranyltranstransferase inhibitor | 0.041 0.036 CID_186984 | ||
| 0.135 | 0.09 | 0.135 | Acetylcholine M1 receptor antagonist | |||
| 0.058 | 0.015 | 0.058 | Cytokine production stimulant | |||
| 0.138 | 0.095 | 0.138 | Interferon gamma antagonist | |||
| 0.087 | 0.044 | 0.087 | Na+ K+ transporting ATPase inhibitor | |||
| 0.07 | 0.029 | 0.07 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.071 | 0.031 | 0.071 | Biliverdin reductase inhibitor | 0.059 0.041 CID_186984 | ||
| 0.056 | 0.017 | 0.056 | Histamine H2 receptor agonist | |||
| 0.069 | 0.03 | 0.069 | Calcium channel P-type blocker | |||
| 0.057 | 0.019 | 0.057 | Dopamine beta hydroxylase inhibitor | |||
| 0.078 | 0.041 | 0.078 | Glycine receptor agonist | |||
| 0.082 | 0.046 | 0.082 | Catalase inhibitor | |||
| 0.067 | 0.033 | 0.067 | Ribonucleotide reductase inhibitor | 0.049 0.043 CID_186984 | ||
| 0.048 | 0.014 | 0.066 | Antibiotic Aminoglycoside-like | 0.066 0.007 CID_186984 | CID_186984 | |
| 0.061 | 0.028 | 0.061 | Pregnane X receptor antagonist | |||
| 0.038 | 0.005 | 0.038 | Acid ceramidase inhibitor | |||
| 0.059 | 0.026 | 0.059 | Antimetabolite | 0.043 0.038 CID_186984 | ||
| 0.057 | 0.024 | 0.057 | Squalene epoxidase inhibitor | |||
| 0.037 | 0.005 | 0.037 | Vanilloid 2 agonist | 0.026 0.016 CID_186984 | ||
| 0.07 | 0.039 | 0.07 | Glutamate (mGluR6) antagonist | |||
| 0.064 | 0.032 | 0.064 | Ribonucleoside-diphosphate reductase inhibitor | 0.047 0.043 CID_186984 | ||
| 0.05 | 0.019 | 0.05 | Histamine H1 receptor agonist | |||
| 0.049 | 0.018 | 0.049 | Dopamine D5 agonist | |||
| 0.053 | 0.022 | 0.053 | Oxytocin agonist | |||
| 0.087 | 0.057 | 0.087 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.047 | 0.017 | 0.047 | Kainate receptor agonist | |||
| 0.065 | 0.035 | 0.065 | Carbonic anhydrase stimulant | |||
| 0.083 | 0.053 | 0.083 | CC chemokine 5 receptor agonist | |||
| 0.121 | 0.092 | 0.121 | Protein kinase stimulant | |||
| 0.037 | 0.008 | 0.037 | Purinergic P2Y15 antagonist | 0.03 0.016 CID_186984 | ||
| 0.247 | 0.218 | 0.247 | Apoptosis agonist | |||
| 0.051 | 0.023 | 0.051 | Toll-Like receptor 2 agonist | 0.036 0.033 CID_186984 | ||
| 0.101 | 0.074 | 0.101 | DOPA decarboxylase inhibitor | |||
| 0.086 | 0.059 | 0.086 | Histamine N-methyltransferase inhibitor | |||
| 0.046 | 0.02 | 0.046 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.034 | 0.008 | 0.034 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.019 CID_186984 | ||
| 0.145 | 0.119 | 0.145 | Death-associated protein kinase 2 inhibitor | |||
| 0.03 | 0.004 | 0.03 | Carbonic anhydrase X inhibitor | 0.016 0.012 CID_186984 | ||
| 0.03 | 0.004 | 0.03 | Carbonic anhydrase VIII inhibitor | 0.016 0.012 CID_186984 | ||
| 0.061 | 0.036 | 0.061 | Ryanodine receptor antagonist | |||
| 0.082 | 0.057 | 0.082 | Glutathione S-transferase inhibitor | |||
| 0.044 | 0.021 | 0.044 | Membrane dipeptidase inhibitor | 0.037 0.032 CID_186984 | ||
| 0.093 | 0.07 | 0.093 | Carbonic anhydrase III inhibitor | |||
| 0.102 | 0.079 | 0.102 | Electron transport complex I inhibitor | |||
| 0.133 | 0.111 | 0.133 | CF transmembrane conductance regulator agonist | |||
| 0.04 | 0.019 | 0.04 | Fumarate hydratase inhibitor | 0.036 0.022 CID_186984 | ||
| 0.132 | 0.11 | 0.132 | Melanin inhibitor | |||
| 0.093 | 0.072 | 0.093 | Nitric-oxide synthase inhibitor | |||
| 0.042 | 0.023 | 0.042 | AMPA 4 receptor antagonist | |||
| 0.024 | 0.004 | 0.024 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.018 0.009 CID_186984 | ||
| 0.053 | 0.034 | 0.053 | Aconitate hydratase inhibitor | |||
| 0.133 | 0.115 | 0.133 | Dual specificity phosphatase inhibitor | |||
| 0.041 | 0.023 | 0.041 | Diamine oxidase inhibitor | |||
| 0.102 | 0.085 | 0.102 | TRPA1 agonist | |||
| 0.039 | 0.023 | 0.039 | Glutamate (mGluR8) agonist | |||
| 0.063 | 0.047 | 0.063 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.054 | 0.039 | 0.054 | Glucosylceramidase inhibitor | |||
| 0.029 | 0.014 | 0.029 | Hedgehog signaling activator | |||
| 0.043 | 0.028 | 0.043 | Angiotensin AT1 receptor antagonist | |||
| 0.02 | 0.005 | 0.02 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.079 | 0.065 | 0.079 | Inducible nitric-oxide synthase inhibitor | |||
| 0.178 | 0.165 | 0.178 | Neuropeptide Y2 antagonist | |||
| 0.047 | 0.034 | 0.047 | Benzodiazepine antagonist | |||
| 0.035 | 0.023 | 0.035 | Angiotensin II receptor antagonist | |||
| 0.029 | 0.018 | 0.029 | Estrogen-related receptor gamma antagonist | |||
| 0.085 | 0.074 | 0.085 | Glutamate release inhibitor | |||
| 0.059 | 0.048 | 0.059 | NMDA receptor agonist | |||
| 0.053 | 0.043 | 0.053 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.091 | 0.081 | 0.091 | Carbonic anhydrase XV inhibitor | |||
| 0.044 | 0.036 | 0.044 | Adenosine deaminase inhibitor | |||
| 0.114 | 0.106 | 0.114 | Nav1.6 sodium channel blocker | |||
| 0.021 | 0.013 | 0.021 | Toll-Like receptor 8 agonist | |||
| 0.021 | 0.014 | 0.021 | Neuraminidase (Influenza B) inhibitor | |||
| 0.054 | 0.047 | 0.054 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.098 | 0.091 | 0.098 | Cholesterol synthesis inhibitor | |||
| 0.07 | 0.063 | 0.07 | Potassium channel (Tandem pore domain) blocker | |||
| 0.029 | 0.023 | 0.029 | Peptide deformylase inhibitor | |||
| 0.026 | 0.021 | 0.026 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.035 | 0.03 | 0.035 | Delayed rectifier potassium channel blocker | |||
| 0.033 | 0.03 | 0.033 | Adenosine uptake inhibitor | |||
| 0.036 | 0.033 | 0.036 | Dihydropteroate synthase inhibitor | |||
| 0.015 | 0.012 | 0.015 | Thromboxane A2 agonist | |||
| 0.062 | 0.059 | 0.062 | Glutamate (mGluR7) antagonist | |||
| 0.031 | 0.029 | 0.031 | Kainate receptor 2 antagonist | |||
| 0.017 | 0.015 | 0.017 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.038 | 0.036 | 0.038 | Guanylate cyclase inhibitor | |||
| 0.146 | 0.144 | 0.146 | Neurotrophic factor enhancer | |||
| 0.162 | 0.161 | 0.162 | Calpain inhibitor | |||
| 0.012 | 0.011 | 0.012 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.012 | 0.011 | 0.012 | Carbonic anhydrase XI inhibitor | |||
| 0.031 | 0.03 | 0.031 | Phosphoglycerate kinase inhibitor | |||
| 0.008 | 0.281 | 0.044 | HIV-1 protease inhibitor | 0.044 0.029 CID_186984 | CID_186984 | |
| 0.004 | 0.746 | 0.662 | Cyclin B inhibitor | 0.662 0.003 CID_186984 | CID_186984 | |
| 0.004 | 0.901 | 0.105 | CDK2/cyclin A inhibitor | 0.105 0.053 CID_186984 | CID_186984 | |
| 0.003 | 0.924 | 0.51 | Cyclin-dependent kinase 5 inhibitor | 0.51 0.004 CID_186984 | CID_186984 | |
| 0.003 | 0.966 | 0.628 | Dyrk kinase inhibitor | 0.628 0.005 CID_186984 | CID_186984 | |
| 0.003 | 0.967 | 0.675 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.675 0.005 CID_186984 | CID_186984 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |